Philippine Nurses Association (PNA), the accredited professional organization for nursing in the country, has given its take on the recent issue involving Department of Health (DOH) and Sanofi-Pasteur dengue vaccine.
In a statement signed by president Ruthelma Tingda, PNA said that it’s very firm on its advocacy regarding patient safety which included proper drug administration.
DOH reported that it has injected in phases a total of 733,000 children aged 9-14 years old with Dengvaxia through the health department’s School Based Immunization Program which started in the previous administration.
The nursing organization also said that it supports the ongoing investigation on the Dengvaxia procurement, in order to “fortify measures that will provide protection to these vulnerable members of our country.”
Here’s PNA full statement:
Human life is inviolable. Quality and excellence in the care of the patients are the goals of nursing practice. Accurate documentation of actions and outcomes of delivered care is the hallmark of nursing acountability. These are the ethical principles, under Section 6 of the Code of Ethics for Nurses, that steady emphasize on the significance of patient safety.
Given the recent reported incidents on the dengue vaccines that had risked the health and had ultimately, claimed the lives of some Filipino children, the Philippine Nurses Association strongly supports the ongoing investigation to fortify measures that will provide protection to these vulnerable members of our country.
Furthermore, PNA continues to be firm in its advocacy for patient safety, that includes but is not limited to proper drug administration.